Skip to main content
. 2021 Feb 15;2021:6667006. doi: 10.1155/2021/6667006

Figure 1.

Figure 1

Schematic representation of the timings of treatment with disease-modifying drugs for MS that are hypothesised to act as immune reconstitution inhibitors, with regard to planning a pregnancy. Timings refer to the second year of a two-year course of treatment. If a patient becomes pregnant after only one course of treatment, the second course must be delayed until after the pregnancy (see text).